Perritt Capital Management’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,750
Closed -$30.8K 306
2024
Q2
$30.8K Buy
+8,750
New +$44.6K 0.02% 240
2024
Q1
Sell
-5,313
Closed -$53.1K 335
2023
Q4
$53.1K Hold
5,313
0.03% 220
2023
Q3
$36.6K Sell
5,313
-625
-11% -$6.19K 0.02% 225
2023
Q2
$64.6K Sell
5,938
-2,500
-30% -$29.6K 0.04% 211
2023
Q1
$126K Buy
8,438
+5,313
+170% +$115K 0.07% 176
2022
Q4
$83.8K Hold
3,125
0.05% 207
2022
Q3
$98K Sell
3,125
-625
-17% -$16.2K 0.06% 174
2022
Q2
$87K Hold
3,750
0.05% 173
2022
Q1
$134K Hold
3,750
0.07% 179
2021
Q4
$117K Hold
3,750
0.06% 193
2021
Q3
$135K Hold
3,750
0.07% 183
2021
Q2
$120K Hold
3,750
0.06% 193
2021
Q1
$164K Buy
3,750
+625
+20% +$32K 0.09% 177
2020
Q4
$125K Hold
3,125
0.08% 176
2020
Q3
$173K Hold
3,125
0.13% 154
2020
Q2
$181K Sell
3,125
-625
-17% -$35K 0.14% 153
2020
Q1
$215K Sell
3,750
-4,375
-54% -$133K 0.18% 143
2019
Q4
$197K Hold
8,125
0.09% 187
2019
Q3
$211K Buy
8,125
+3,125
+63% +$75.8K 0.09% 198
2019
Q2
$104K Hold
5,000
0.04% 227
2019
Q1
$100K Hold
5,000
0.04% 217
2018
Q4
$68K Buy
+5,000
New +$112K 0.03% 218

Other funds holding BMRA

Perritt Capital Management's BMRA Position: Q3 2024 in Review

Perritt Capital Management sold out of Biomerica (BMRA) in Q3 2024, closing a stake of 8,750 shares — an estimated $30.8K sold.

Perritt Capital Management first reported a position in BMRA in Q4 2018 and held it in 22 quarters. The position peaked at $215K in Q1 2020. 25 funds tracked by Wall St. Rank hold BMRA as of Q3 2024.

  • Perritt Capital Management reported no remaining Biomerica position as of Q3 2024 after selling out during the quarter.
  • Perritt Capital Management sold 8,750 Biomerica shares in Q3 2024, an estimated $30.8K.
  • Perritt Capital Management first reported a position in Biomerica in Q4 2018 and held it in 22 quarters.
  • Perritt Capital Management's Biomerica position peaked at $215K in Q1 2020.
  • 25 funds tracked by Wall St. Rank held Biomerica as of Q3 2024.

Based on Perritt Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.